Duke’s Califf Bows Out Of FDA Search; Quest Moves To Baltimore, New York
This article was originally published in The Pink Sheet Daily
Executive Summary
Baltimore Health Commissioner Sharfstein would appear to be the favorite, but former New York City health official Hamburg is said to be on the shortlist.
You may also be interested in...
FDA Chief Scientist Ostroff Named Acting Head With Hamburg On Way Out
Margaret Hamburg’s background in public health, as opposed to academic medicine, was off-putting to some in pharma initially, but she’ll leave the agency in March with high drug approval numbers and praise from industry groups. Chief Scientist Stephen Ostroff has been named acting head, and some speculate that Robert Califf, newly appointed deputy commissioner for medical products and tobacco, is in line to succeed Hamburg on a permanent basis.
FDA Lands Califf As Top Deputy, Potential Next Commissioner
Renowned cardiologist and clinical trial researcher Robert Califf will join FDA in February as deputy commissioner for medical products and tobacco. Califf is director of Duke University’s Translational Medicine Institute and vice chancellor for Clinical and Translational Research.
FDA Lands Califf As Top Deputy, Potential Next Commissioner
Renowned cardiologist and clinical trial researcher Robert Califf will join FDA in February as deputy commissioner for medical products and tobacco. Califf is director of Duke University’s Translational Medicine Institute and vice chancellor for Clinical and Translational Research.